market Reports

Non Small Cell Lung Cancer Therapeutics Market Size, Share, Growth | Global Industry Research Report, 2026

SKU ID : FBUIN-15633850 | Publishing Date : 01-Jul-2019 | No. of pages : 160

Detailed TOC of Non Small Cell Lung Cancer Therapeutics Market Size, Share, Growth | Global Industry Research Report, 2026

The global non small cell lung cancer (NSCLC) therapeutics market size was valued at USD 16,011.7 Million in 2018 and is projected to reach USD 43,713.1 Million by the end of 2026, exhibiting a CAGR of 13.4% in the forecast period (2019-2026). 

Keyplayers in Non Small Cell Lung Cancer Therapeutics Market Size, Share, Growth | Global Industry Research Report, 2026

Genentech (F. Hoffmann-La Roche Ltd)
Eli Lilly and Company
Celgene Corporation
AstraZeneca
Pfizer Inc.
Sanofi
Novartis AG
Astellas
Bristol Myers Squibb
Boehringer Ingelheim Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. (Takeda)
Merck Sharp & Dohme Corp.
Other players
PRICE
4850
8850

6850


    • market Reports market Reports